Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

398
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-Reactivity and Cross-Intolerance Among Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Clinical Patterns, COX-1-Mediated Mechanisms, and Implications for COX-2 Inhibitors and Paracetamol.

International journal of molecular sciences·2026
Same author

Delayed-Type Hypersensitivity to <i>Mycobacterium tuberculosis</i> Antigens: The Immunological Mechanism and Potential Therapeutic Strategies-A Systematic Review.

International journal of molecular sciences·2026
Same author

Hypersensitivity Reactions to Benzodiazepines Used for Perioperative Premedication: A Narrative Review.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Possible Crosstalk Between Small Intestinal Bacterial Overgrowth (SIBO) and Atopic Manifestations-A Short Overview.

International journal of molecular sciences·2026
Same author

Self-administered complementary and alternative methods of treating mental disorders among students in Wrocław: a cross-sectional study.

Frontiers in public health·2026
Same author

IL-31/33 Axis in Atopic Dermatitis.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jul 2, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.3K

ADAM33's Role in Asthma Pathogenesis: An Overview.

Jakub Sleziak1, Antoni Gawor1, Marta Błażejewska1

  • 1Student Research Group of Internal Medicine and Allergology, Wroclaw Medical University, 50-367 Wroclaw, Poland.

International Journal of Molecular Sciences
|February 24, 2024
PubMed
Summary

The ADAM33 gene significantly impacts asthma development and severity by influencing airway remodeling and hyperresponsiveness. Understanding its genetic and functional roles offers new therapeutic targets for asthma management.

Keywords:
ADAM33a disintegrin and metalloprotease 33airway remodelingasthmapolymorphism

More Related Videos

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

43.0K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.7K

Related Experiment Videos

Last Updated: Jul 2, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.3K
Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

43.0K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.7K

Area of Science:

  • Genetics
  • Pulmonology
  • Immunology

Background:

  • Asthma is a chronic respiratory disease with complex genetic underpinnings.
  • The ADAM33 gene has emerged as a significant factor in asthma pathogenesis.
  • Its role in airway remodeling and hyperresponsiveness is crucial.

Purpose of the Study:

  • To review the genetic and functional aspects of ADAM33 in asthma.
  • To highlight genetic variants associated with asthma susceptibility and severity.
  • To discuss ADAM33's potential as a therapeutic target.

Main Methods:

  • Literature review of genetic and functional studies on ADAM33 in asthma.
  • Analysis of ADAM33's role in airway remodeling and smooth muscle cell proliferation.
  • Examination of ADAM33's interaction with environmental factors.

Main Results:

  • Specific genetic variants of ADAM33 are linked to increased asthma risk and severity.
  • ADAM33 influences airway remodeling and bronchial hyperresponsiveness.
  • ADAM33 interacts with environmental factors in asthma development.

Conclusions:

  • ADAM33 is a key genetic determinant in asthma.
  • Targeting ADAM33 presents a promising strategy for novel asthma therapies.
  • Further research into ADAM33's mechanisms can improve asthma management.